Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy

Thyroid

Volumn 7, Issue 4, 1997, Pages 579-585

  Baschieri, Lidio ^a   Antonelli, Alessandro ^a,c   Nardi, Stefano ^a   Alberti, Baldassare ^a   Lepri, Antonio ^a   Canapicchi, Raffaele ^b   Fallahi, Poupak ^a  

^a UNIVERSITY OF PISA   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

^c Istituto di Clinica Medica II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EXOPHTHALMOS; EYE DISEASE; GASTRITIS; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030800842     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.579     Document Type: Article

References (42)

1. Wall JR 1984 Autoimmunity and Graves' ophthalmopathy. In: German CA, Waller RR, Dyer JA (ed) The Eye and Orbit in Thyroid Disease. Raven Press, New York, p 103.
2. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A 1989 Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radiodine therapy for hyperthyroidism. N Engl J Med 20:1349-1352.
3. Werner SC 1966 Prednisone in the emergency treatment of malignant exophthalmos. Lancet 1:1004-1007.
4. Garber MI 1966 Methyprednisolone in the treatment of exphthalmos. Lancet 1:958-960.
5. Donaldson SS, Bagshaw MA, Kriss JP 1973 Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 37:276-285.
6. Burrow GN, Mitchell MS, Howard RO 1970 Immunosup-pressive therapy for the eye changes of Graves' disease. J Clin Endocrinol Metab 31:307-311.
7. Bigos ST, Nisula BC, Daniels GH, Eastman RC, Johnston HH, Kohler PO 1979 Cyclophosphamide in the management of advanced Graves' ophthalmopathy: A preliminary report. Ann Intern Med 90:921-923.
8. Prummel MF, Mourits MP, Berghout A, Krenning EP, Van Der Gaag R, Koornneef L, Wiersinga WM 1989 Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med 321:1353-1359.
9. Dandona P, Marshall NJ, Bidey SP, Nathan A, Havard CWH 1979 Successful treatment of exophathalmos and pretibial myxoedema with plasma-pheresis. Br Med J 1:374-376.
10. Catz B, Perzik SL 1965 Subtotal vs. total surgical ablation of the thyroid, malignant exophthalmos and its relation to remnant thyroid. In: Cassano C, Andreoli M (ed) Current Topics in Thyroid Research. Academic Press, New York, p 1183.
11. Gorman CA 1986 Extrathyroid manifestation of Graves' disease. In: Ingbar SH, Brayerman LE (ed) The Thyroid. JB Lippincott Company, Philadelphia, p 1015.
12. Char DH 1991 The ophthalmopathy of Graves' disease. Med Clin North Am 75:97-119.
13. Imbach P, Wagner HP, Berchtold WP, Gaedicke G, Hirt A, Joller P, Mueller-Eckhardt C, Muller B, Rossi E, Baranown S 1985 Intravenous immunoglobulin versus oral corticosteroids in acute thrombocytopenic purpura in childhood. Lancet II:464-468.
14. Finn NG, Wang JC, Hong KJ 1987 High-dose intravenous immunoglobulin infusion in the treatment of thrombotic thrombocytopenic purpura. Arch Intern Med 147:2165-2167.
15. Pollack S, Cunningham-Rundles C, Smithwick EM, Barandun S, Good RA 1982 High-dose intravenous gamma globulin for autoimmune neutropenia. N Engl J Med 307:253.
16. Palla R, Cirami C, Panichi V, Bianchi AM, Parrini M, Grazi G 1991 Intravenous immunoglobulin therapy of membranous nephropathy: Efficacy and safety. Clin Nephrol 35:98-104.
17. Gadjos PH, Outin H, Elkharrat D, Brunel D, de Rohan-Chabot P, Raphael JC, Goulon M, Goulon-Goeau C, Morel E 1984 High-dose intravenous immunoglobulin for myasthenia gravis. Lancet 1:406-407.
18. Roifman CM, Schaffer MF, Wachsmuth SE, Murphy G, Gelfand EW 1987 Reversal of chronic polymyositis following intravenous immune serum globulin therapy. JAMA 258:513-515.
19. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy W, Sanders SP, Shulman ST, Wiggins JW, Hicks RV, Fulton DR, Lewis AB, Leung DYM, Colton T, Rosen FS, Melish ME 1986 The treatment of Kawasaky syndrome with intravenous gamma globulin. N Engl J Med 315:342-347.
20. Philipsen EK, Larsen S, Helin P 1989 A preliminar trial of High-dose intravenous immunoglobulin to a patient with euthyroid ophthalmopathy. Thyroidology 2:93-95.
21. Dweyer JM, Benson EM, Currie JN, O'Day J 1991 Intravenously administered IgG for the treatment of thyroid eye disease. In: Imbach P (ed) Immunotherapy with Intravenous Immunoglobulins. Academic Press, London, p 387.
22. Antonelli A, Saracino A, Lepri A, Alberti B, Bassi R, Baschieri L 1990 Graves' ophthalmopathy treated with human gammaglobulin: preliminary results [abstract]. J Endocrinol Invest 13(Suppl 1):59.
23. Antonelli A, Saracino A, Lepri A, Alberti B, Bassi R, Bertoni F, Baschieri L 1991 Results of gammaglobulin intravenous treatment combined with orbital radiotherapy in Graves' ophthalmopathy (G.O.). 10th International Thyroid Conference, The Hague, ML, Abstractbook p. 79.
24. Antonelli A, Saracino A, Alberti B, Canapicchi R, Cartei F, Lepri A, Laddaga M, Baschieri L 1992 High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy Acta Endocrinol (Copenh) 126:13-23.
25. Werner SC 1977 Modification of the classification of the eye changes of Graves' disease: Recomendation of the ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 44:203-204.
26. Prummel MF, Mourits MPh, Blank L, Berghout A, Koornneef L, Wiersinga WM 1993 Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 342:949-954.
27. Marushak D, Faurschou S, Blichert-Toft M 1984 Regression of ophthalmopathy in Graves' disease following thyroidectomy. Acta Ophthalmol (Copenh) 62:767-779.
28. Kahaly G, Schrezenmeir J, Krause U, Schweikert B, Meuer S, Muller W, Dennebaum R, Beyer J 1986 Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: A controlled, randomized and prospective study. Eur J Clin Invest 16:415-422.
29. Bartalena L, Marcocci C, Chiovato L, Laddaga M, Lepri G, Andreani D, Cavallacci G, Baschieri L, Pinchera A 1983 Orbital cobalt irradiation combined with systemic corticosteroids for Graves' Ophthalmopathy: Comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 56:1139-1144.
30. Haddad HM 1973 Pathogenesis and treatment of endocrine exophthalmos. Int Surg 58:482-484.
31. Mulhrein JL, Temple TE, Cundey DW 1972 Glucocorticoid treatment of progressive infiltrative ophthalmopathy. South Med J 65:77-80.
32. Desanto LW 1980 The total rehabilitation of Graves' ophthalmopathy. Laryngoscope 90:1652-1678.
33. Eibl MM, Cairns L, Rosen SF 1984 Safety and efficacy of a monomeric, functionally intact intravenous IgG preparation in patients with primary immunodeficiency syndromes. Clin Immunol Immunopathol 31:151-160.
34. Van Schaik IN, Lundkvist I, Vermeulen M, Brand A 1992 Pouvaient immunoglobulin for intravenous use interferes with cell proliferation in vitro. J Clin Immunol 12:1-10.
35. Tomino Y, Sakai H, Takaya M, Miura M, Suga T, Endoh M, Nomoto Y 1984 Solubilization of intraglomerular deposits of IgG immune complexes by human sera or gamma-globulin in patients with lupus nephritis. Clin Exp Immunol 58:42-48.
36. Palla R, Cirami C, Panichi V, Bianchi M, Parrini M, Grazi G 1991 Intravenous immunoglobulin therapy of membranous nephropathy: Efficacy and safety. Clin Nephrol 35:98-104.
37. Antonelli A, Palla R, Casarosa L, Fallahi P, Baschieri L 1996 IgG, IgA and C3 deposits in the extra-thyroidal manifestations of autoimmune Graves' disease: Their in vitro solubilization by intravenous immunoglobulin. Clin Exp Rheumatol 14(Suppl. 15):S31-S35.
38. Antonelli A, Navarranne A, Palla R, Alberti B, Saracino A, Mestre C, Roger P, Agostini S, Baschieri L 1994 Pretibial myxedema and high-dose intravenous immunoglobulin treatment. Thyroid 4:399-408.
39. Van Schaik IN 1995 Antibody response and intravenous immunoglobulin treatment in immune-mediated peripheral neuropathies. Cip-Gegevens Koninklijke Bibliotheek, Den Haag. Amsterdam.
40. Dietrich G, Kazatchkine MD 1990 Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies. J Clin Invest 85:620-625.
41. Dietrich G, Kaveri Sv, Kazatchkine MD 1992 Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol 62:S73-S81.
42. Eibl MM 1990 Gamma globulin therapy. Curr Opin Pediatr 2:935-940.